Corticosteroid use does not appear to increase infectious complications in non-COVID-19 pneumonia

https://www.acpjournals.org/doi/10.7326/ANNALS-25-03055

Annals of Internal Medicine

In severe pneumonia and ARDS, adjunct corticosteroids probably reduce short-term mortality. In severe pneumonia, they may reduce secondary shock. In both conditions, corticosteroids may have little or no effect on hospital-acquired infections.